Point72 »

Biogen Idec shares owned by Point72

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Point72 from 13F filings

Historical chart of Point72 investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Point72 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Point72

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.6M 29k 193.84
2024-06-30 $17M 73k 231.82
2024-03-31 $6.0M 28k 215.63

More positions owned by Point72

Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Broadcom Call Option (AVGO)
Cisco Systems Call Option (CSCO)
Nike CL B Call Option (NKE)
Deere & Company Call Option (DE)
Adobe Systems Incorporated (ADBE)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Bristol Myers Squibb Call Option (BMY)
Accenture Plc Ireland Shs Class A Call Option (ACN)
NVIDIA Corporation Call Option (NVDA)
McKesson Corporation (MCK)
Bruker Corporation (BRKR)
General Motors Company (GM)

View all positions for Point72

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Wellington Management Company
T. Rowe Price Investment Management
Geode Capital Management
Pacer Advisors
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Legal & General Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec